following an abbreviated submission:
dorzolomide / timolol preservative-free unit-dose eye drops (COSOPT®) are accepted for restricted use in NHS Scotland for the treatment of elevated intra-ocular pressure in patients with open-angle glaucoma and pseudo-exfoliative glaucoma when topical beta-blocker monotherapy is not sufficient.
This preparation is substantially more expensive than the equivalent multi-dose eye drop preparation and should be restricted to use in patients for whom a combination of these two agents is appropriate and who have proven sensitivity to the preservative benzalkonium chloride.
Download detailed advice29KB (PDF)
- Medicine name:
- dorzolamide + timolol (Cosopt)
- SMC ID:
- Elevated intra-ocular pressure in patients with open-angle glaucoma and pseudo-exfoliative glaucoma
- Pharmaceutical company
- BNF chapter
- Submission type
- Date advice published:
- 11 December 2006